Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study

Tomsitz, D; Ruf, T; Heppt, M; Staeger, R; Ramelyte, E; Dummer, R; Garzarolli, M; Meier, F; Meier, E; Richly, H; Gromke, T; Siveke, JT; Franklin, C; Klespe, KC; Mauch, C; Kilian, T; Seegräber, M; Schilling, B; French, LE; Berking, C; Heinzerling, L

Heinzerling, L (通讯作者),Ludwig Maximilian Univ LMU Munich, Univ Hosp, Dept Dermatol & Allergy, D-80337 Munich, Germany.

CANCERS, 2023; 15 (13):

Abstract

Simple Summary Tebentafusp has recently been approved for the treatment of metastatic uveal melanoma (mUM). We performed a retrospective, multicenter ......

Full Text Link